Update on community-acquired pneumonia - New pathogens and new concepts in treatment

被引：6

作者：

Mandell, Lionel A. ^{[1
]}

机构：

[1] McMaster Univ, Fac Hlth Sci, Div Infect Dis, Hamilton, ON, Canada

来源：

POSTGRADUATE MEDICINE | 2005年 / 118卷 / 04期

关键词：

D O I：

10.3810/pgm.2005.10.1699

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Recent years have witnessed the emergence of new pathogens linked to community-acquired pneumonia (CAP) along with new antibiotics designed to combat them. In this article, Dr Mandell presents an expert's view on these developments in the context of treatment guidelines for CA P. He also explores monotherapy versus combination therapy, the efficacy of rapid initiation of treatment, and short,course therapy as a hedge against antimicrobial resistance.

引用

页码：35 / +

页数：8

共 25 条

[1] Efficacy and safety of tifacogin (recombinant tissue factor pathway inhibitor) in severe sepsis -: A randomized controlled trial [J].

Abraham, E ;

Reinhart, K ;

Opal, S ;

Demeyer, I ;

Doig, C ;

Rodriguez, AL ;

Beale, R ;

Svoboda, P ;

Laterre, PF ;

Simon, S ;

Light, B ;

Spapen, H ;

Stone, J ;

Seibert, A ;

Peckelsen, C ;

De Deyne, C ;

Postier, R ;

Pettilä, V ;

Sprung, CL ;

Artigas, A ;

Percell, SR ;

Shu, V ;

Zwingelstein, C ;

Tobias, J ;

Poole, L ;

Stolzenbach, JC ;

Creasey, AA .

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2003, 290 (02) :238-247

[2] Community-acquired pneumonia in adults: Guidelines for management [J].

Bartlett, JG ;

Breiman, RF ;

Mandell, LA ;

File, TM .

CLINICAL INFECTIOUS DISEASES, 1998, 26 (04) :811-838

[3]

Bartlett John G., 2000, Clinical Infectious Diseases, V31, P347, DOI 10.1086/313954

[4]

Dunbar LM, 2003, CLIN INFECT DIS, V37, P1147

[5] High-dose, short-course Levofloxacin for community-acquired pneumonia: A new treatment paradigm [J].

Dunbar, LM ;

Wunderink, RG ;

Habib, MP ;

Smith, LG ;

Tennenberg, AM ;

Khashab, MM ;

Wiesinger, BA ;

Xiang, JX ;

Zadeikis, N ;

Kahn, JB .

CLINICAL INFECTIOUS DISEASES, 2003, 37 (06) :752-760

[6] Drotrecogin alfa (activated) administration across clinically important subgroups of patients with severe sepsis [J].

Ely, EW ;

Laterre, PF ;

Angus, DC ;

Helterbrand, JD ;

Levy, H ;

Dhainaut, JF ;

Vincent, JL ;

Macias, WL ;

Bernard, GR .

CRITICAL CARE MEDICINE, 2003, 31 (01) :12-19

[7] Associations between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia [J].

Gleason, PP ;

Meehan, TP ;

Fine, JM ;

Galusha, DH ;

Fine, MJ .

ARCHIVES OF INTERNAL MEDICINE, 1999, 159 (21) :2562-2572

[8] A short (3-day) course of azithromycin tablets versus a 10-day course of amoxycillin-clavulanic acid (co-amoxiclav) in the treatment of adults with lower respiratory tract infections and effects on long-term outcome [J].

Hoepelman, IM ;

Mollers, MJ ;

van Schie, MH ;

Greefhorst, APM ;

Schlosser, NJJ ;

Damste, EJS ;

van de Moosdijk, CNF ;

Dalinghaus, WH ;

Eland, ME ;

Mol, SJM ;

Rozenberg-Arska, M .

INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 1998, 9 (03) :141-146

[9] SARS-associated coronavirus [J].

Holmes, KV .

NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (20) :1948-1951

[10] Timing of antibiotic administration and outcomes for medicare patients hospitalized with community-acquired pneumonia [J].

Houck, PM ;

Bratzler, DW ;

Nsa, W ;

Ma, A ;

Bartlett, JG .

ARCHIVES OF INTERNAL MEDICINE, 2004, 164 (06) :637-644

← 1 2 3 →